Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Treating Tumors Using Subtractive Approach to Remove Molecules Suppressing Immune System with Amir Jafri Immunicom TRANSCRIPT
Download PDFNov 9, 2022
Amir Jafri is the CEO and Founder of Immunicom, targeting the molecules and proteins produced by cancer. Using a subtractive approach, Immunicom has developed technology intended to remove the elements that are suppressing the immune system and allowing the tumor to shield itself from the immune system. After treatment, patients in clinical trials are seeing immune cells infiltrate their solid tumor cancers.
Amir explains, "What we will do is then design our own molecules that will neutralize what the molecule of cancer is producing. But instead of making our molecule into a drug, which is normally what would happen, we actually put it into this proprietary liquid cartridge that we have. It's got a liquid chemical matrix, and there's like a little cartridge, and our molecule goes in there. That cartridge attaches to what's called a plasmapheresis machine."
"Now, that machine is very similar to a dialysis machine. These machines exist all over the world and they've been around for 30 years. The patient sits down, and their blood and plasma attach to the machine. They just sit in a comfortable chair, and their plasma is then taken by the machine and sent through our cartridge. And then we will pull out, in a very, very exquisite way, the molecule that the cancer is producing that is suppressing the immune system."
@Immunicom #ImmuneSystem #Immunotherapy #MedicalDevice #HealthTech #MedTech #Oncology #Cancer #Tumors
